Studying the educational package based on Iranian medicine in the prevention of neonatal jaundice

Not Applicable

• Conditions: eonatal jaundice.; Neonatal jaundice, unspecified; P59.9

• Registration Number: IRCT20230225057535N1
• Lead Sponsor: Fasa University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 June 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Women in the 32nd week of pregnancy, consent to participate in the study, not having allergies to the recommended foods

Exclusion Criteria

Lack of consent to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison bilirubin levels in intervention and control groups on 3, 6, 9, 12,15, and 20 days after delivery. Timepoint: Normal bilirubin level in newborns. Method of measurement: The blood sample of the newborn in the heel part of the intervention and control group will be taken by a trained nurse during 3, 6, 9, 12, 15, and 20 days after birth in the hospital, and bilirubin levels will be measured in the reference laboratory.